This authoritative reference work provides a detailed study of recent developments in artificial cells, cell engineering and cell therapy. It covers design, engineering and uses of artificial cells. The clinical relevance of artificial cells and cell engineering is assessed. This is a highly dynamic sector with growing interest in the use of engineered cells in controlled release of active drugs and other therapeutic agents.
Key Features: introduces the basics of artificial cell technology; provides a comprehensive study of the most recent advances in artificial cells, cell engineering and cell therapy; discusses the design, engineering and uses of artificial cells; looks at artificial cells as blood substitutes and their potential use in treating kidney diseases, diabetes and cancer; a valuable reference for researchers, students and practitioners in the field.
Contents: Part 1 The artificial cell: Introduction to artificial cells: concept, history, design, current status and future; Polymeric hydrophilic polymers in targeted drug delivery; The artificial cell design: liposomes; The artificial cell design: Nanoparticles. Part 2 Cell engineering: The cutting edge: Apoptosis and therapeutic opportunity; Bone marrow stromal cells in myocardial regeneration and the role of cell signalling; Musculoskeletal tissue engineering with skeletal muscle-derived stem cells. Part 3 Artificial cells for cell therapy: Artificial cell for oral delivery of live bacterial cells for therapy; Artificial cells in liver disease; Artificial cells as a novel approach to gene therapy; Capillary devices for therapy. Part 4 The clinical relevance of artificial cells and cell engineering: Artificial cells in medicine: with emphasis on blood substitutes; Bone marrow stromal cells as universal donor cells for myocardial regeneration therapy; Myocardial regeneration, tissue engineering and therapy; Kidney diseases and potentials of artificial cells; Engineered cells for treatment of diabetes; Drug delivery system for active brain targeting; Artificial cells in enzyme therapy with emphasis on tyrosinase for melanoma in mice; Stem cell and regenerative medicine: commercial and pharmaceutical implications; Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present therapy and therapeutic potential of cell-based therapy; Inflammatory bowel diseases: Current treatment strategies and potential for drug delivery using artificial cell microcapsules; Carrier-mediated and artificial-cell targeted cancer drug delivery.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Dr Satya Prakash is Director of the Biomedical Technology and Cell Therapy Research Laboratory and Associate Professor of Biomedical Engineering (in the Faculty of Medicine) at the internationally renowned McGill University, Canada. Dr Prakash is highly regarded for his research into artificial cells, cell and tissue engineering, and more recently for his contribution to the development of controlled-release drug delivery systems.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Phatpocket Limited, Waltham Abbey, HERTS, Royaume-Uni
Etat : Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions. N° de réf. du vendeur Z1-E-007-01999
Quantité disponible : 1 disponible(s)
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
Hardcover. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book. N° de réf. du vendeur ERICA75818456903625
Quantité disponible : 1 disponible(s)